Jane Pauley Community Health Center takes over 7 medical practices
The locations include six pediatric practices and one OB/GYN practice in Anderson, Greenwood, Indianapolis and Kokomo.
Health Care & Insurance
Articles
J&J to pay $700M to settle states’ talc-marketing probe
The settlement is part of J&J’s strategy to corral a growing number of suits accusing it of concealing baby powder’s health risks after two failed attempts to use the bankruptcy courts to impose a settlement on former users.
Novartis gets green light for production of cancer drug in Indy
The 70,000-square-foot facility near Indianapolis International Airport will be used to make Pluvicto, which is used to treat advanced-stage prostate cancer who have run out of treatment options.
Elevance Health buys Texas-based chain of infusion centers
Paragon Healthcare Inc., based in suburban Dallas, serves more than 35,000 patients with a broad range of acute and chronic conditions at more than 40 ambulatory infusion centers across eight southern and western states, as well as in patients’ homes.
More hospitals requiring masks as flu, COVID cases surge
While experts say this season likely won’t prove to be as deadly as some other recent winters, it still could mean hundreds of thousands of hospitalizations and many thousands of deaths.
Nevada company sues Lilly for breach of contract over Alzheimer’s drug
Lilly called the lawsuit “baseless” and said PDL BioPharma “has no plausible claim to royalties” for donanemab, which is expected to be approved by the FDA this quarter.
RayzeBio Inc. to be acquired by drugmaker Bristol Myers Squibb for $4.1B
RayzeBio is building a large factory on the northwest side of Indianapolis to make radioisotopes for cancer treatment.
Drugmakers delay in-demand medicines to evade Biden’s new pricing rules
Firms that normally try to sell drugs as soon as possible are suspending clinical trials and shifting timelines, while patient groups are demanding change.
Families say autism therapy helped their kids, but Indiana’s Medicaid cuts could put it out of reach
Providers of the therapy say the new rates are not enough to keep them running and are far below the previous statewide average of $97 per hour.
Kim and Tom Saxton: The myths that hold back health care innovation
Innovating in health care is not just hard and expensive—it is REALLY hard and expensive.
Lilly stock slips after study finds patients who stop Zepbound regain weight
People who stopped taking Eli Lilly and Co.’s blockbuster drug Zepbound after about eight months regained half the weight they’d lost a year later, yet were significantly thinner than when they had started the obesity drug, according to a new study.
Nurses at IU Health’s University, Methodist hospitals eye unionizing
The Indianapolis-based nurses cite poor staffing ratios, patient care and wages as some of the driving reasons behind their efforts.
Up to 5.4M people in U.S. already have had the flu this season
The Centers for Disease Control and Prevention also estimates that flu has caused as many as 55,000 hospitalizations and 4,600 deaths from Oct. 1 through Dec. 2.
White House threatens patents of high-priced drugs developed with taxpayer dollars
The Biden administration is putting pharmaceutical companies on notice, warning them that if the price of certain drugs is too high, the government might cancel their patent protection and allow rivals to make their own versions.
Indiana’s appeals court hears arguments challenging abortion ban
The Court of Appeals of Indiana is considering a challenge to the state’s near total abortion ban on grounds it violates a religious freedom law.
CVS to launch reimbursement model to simplify drug pricing
The biggest U.S. drugstore chain aims to make the payment system more transparent by using a formula based on a drug’s cost, a fixed markup, and a fee that reflects the value of the pharmacy services, the company said Tuesday.
Indianapolis doctor sanctioned by pharmacy board for unsanitary conditions, misbranded drugs
Dr. Leonard Dale Guyer has been the subject of controversy several times over the past two decades.
In race to develop obesity drugs, Roche acquires California biotech for $2.7B
The company, Carmot Therapeutics, has numerous drugs under development. Its lead asset is a once-a-week injection that is in mid-stage development for the treatment of obesity.
OxyContin maker’s bankruptcy deal hits Supreme Court, with billions at stake
The agreement hammered out with state and local governments and victims would provide billions of dollars to combat the opioid epidemic. The decision also has implications for other major product liability lawsuits settled through the bankruptcy system.
Statehouse committee provides updates on Medicaid program changes
An estimated 130,000 Hoosiers over the age of 60 using Medicaid will receive notices in early 2024 advising them to choose a Managed Care Entity to coordinate their health coverage.